Ardent Health, Inc. (NYSE:ARDT - Get Free Report)'s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $13.92, but opened at $13.25. Ardent Health shares last traded at $12.54, with a volume of 154,700 shares traded.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on ARDT shares. Mizuho decreased their price target on shares of Ardent Health from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Bank of America cut shares of Ardent Health from a "neutral" rating to an "underperform" rating and cut their price target for the stock from $15.50 to $14.60 in a research note on Wednesday. Stephens restated an "overweight" rating and set a $21.00 target price on shares of Ardent Health in a research report on Tuesday, May 20th. Guggenheim upped their price target on Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, May 9th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $21.00 price target on shares of Ardent Health in a report on Thursday, May 15th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $20.30.
Check Out Our Latest Stock Analysis on Ardent Health
Ardent Health Stock Performance
The firm has a market cap of $1.66 billion and a P/E ratio of 7.10. The company has a quick ratio of 1.98, a current ratio of 2.12 and a debt-to-equity ratio of 0.70. The firm has a fifty day moving average of $14.00 and a 200-day moving average of $14.03.
Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion during the quarter, compared to analysts' expectations of $1.50 billion. Ardent Health had a net margin of 3.73% and a return on equity of 16.07%. Research analysts predict that Ardent Health, Inc. will post 1.23 earnings per share for the current fiscal year.
Institutional Trading of Ardent Health
Several institutional investors and hedge funds have recently made changes to their positions in ARDT. US Bancorp DE acquired a new stake in shares of Ardent Health during the fourth quarter worth $31,000. Nuveen Asset Management LLC boosted its holdings in Ardent Health by 220.6% during the fourth quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company's stock worth $2,895,000 after buying an additional 116,610 shares during the last quarter. Ventas Inc. bought a new stake in shares of Ardent Health in the 4th quarter valued at about $159,570,000. Barclays PLC boosted its stake in Ardent Health by 24.7% during the 4th quarter. Barclays PLC now owns 26,177 shares of the company's stock worth $447,000 after acquiring an additional 5,185 shares during the last quarter. Finally, Prudential Financial Inc. acquired a new position in Ardent Health during the fourth quarter valued at approximately $481,000.
About Ardent Health
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.